tci Medicare Compliance & Reimbursement - 2016 Issue 16
Industry Note: Part D Prescription Drug Premiums Remain Status Quo
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a CMS update on projected Medicare Part D prescription drug premium trends for CY 2017. It is relevant to clinicians, billing and coding professionals, compliance staff, and healthcare administrators who track Medicare policy updates, beneficiary affordability, and drug cost trends. The piece gives a high-level view of the announcement and places it in the context of rising specialty drug spending and Medicare cost growth.
Why This Topic Matters
Medicare Part D premium changes can affect beneficiary affordability, patient access to medications, and planning for organizations that support Medicare populations. The article also highlights ongoing concern about prescription drug cost growth, which is important for understanding the broader policy environment.
What You Will Learn
- How CMS characterized the projected 2017 Medicare Part D premium outlook
- Why prescription drug cost growth remains a concern in Medicare
- How the update fits into broader discussions of beneficiary affordability and specialty drug pricing
- Which CMS announcement provided the basis for the industry note
Who Should Read This
- Medical coders
- Billing specialists
- Compliance professionals
- Healthcare administrators
- Practice managers
- Revenue cycle staff
- Payer policy analysts
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com